Endpoints News – Biotech and pharma business news, with a focus …
Endpoints News provides up-to-date biotech, drug, pharma, and health news for business and professional readers.
Big dreams dominate among next-gen biotech players
Sep 22, 2024 · Here’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or go down fighting for a landmark change. This marks Carroll’s 20th year selecting top private biotechs for special recognition. Join us at this special event in Boston to recognize this year’s group. sponsored by. see the winners.
News – Endpoints News
Viking CEO on ‘shocking’ market reaction to oral obesity data, preparing for Phase 3. 17 hours ago. R&D. Manufacturing.
Subscribe - Endpoints News
Endpoints Weekly Recaps the most important developments Saturday at 6 AM ET (sample issue) Post-Hoc Analysis and insight from the newsroom, plus dispatches from medical meetings and conferences 1 ...
Eli Lilly resolves shortage for tirzepatide, potentially ending ...
Oct 3, 2024 · Eli Lilly resolves shortage for tirzepatide, potentially ending compounders' run. Ayisha Sharma. News Reporter. Eli Lilly’s blockbuster GLP-1 drug tirzepatide is final ...
Endpoints Cell & Gene Therapy Day | May 11, 2023
12:30pm - 1:25pm ET. The future is now: CGTx innovation, challenges, and perspectives. 1:30pm - 2:25pm ET. The need for speed in CGT manufacturing: Increasing throughput and efficiency through process innovation, automation, and digitization. 2:30pm - 3:25pm ET. The price is right: Approvals & market access in 2023. 3:30pm - 4:30pm ET.
Endpoints Drug Discovery Day
The heat is on to find new ways to advance preclinical drug research. As a new law takes effect aimed at reducing animal testing, Endpoints gathers together a core group of drug discovery experts to explore the real world challenges involved in shifting away from well established animal research practices while simultaneously attempting to streamline projects as demands on nonhuman primate ...
'Moonshot' at liver cell therapy biotech Ambys Medicines comes …
Feb 1, 2023 · Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. Ambys Medicines, backed by Third Rock Ventures and a partner to Takeda, closed its doors in ...
Reader Profile - Endpoints News
ENDPOINTS NEWSDaily at 11:30 AM ET. EARLY EDITIONDaily at 7:15 AM ET. ENDPOINTS PHARMADaily at 3:30 PM ET. BREAKING NEWS ALERTS2-3 times a week. ENDPOINTS FDA+Wed at 2 PM ET. ENDPOINTS ...
Amide Technologies aims to improve peptide manufacturing
Dec 14, 2023 · Amide Technologies is now marketing its peptide manufacturing technology at a time when peptide-based therapies such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro are in high demand. The ...